- Issuer ticker
-
TTOO
- Reported as of
-
06 Aug 2022
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
09 Aug 2022, 16:00:29 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Michael Gibbs, Attorney-in-fact
Key filing fact
Robin Toft filed Form 4 for T2 Biosystems, Inc. (TTOO) on 09 Aug 2022.
Key facts
- This page summarizes Robin Toft's Form 4 filing for T2 Biosystems, Inc. (TTOO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Aug 2022, 16:00.
Change
- Previous filing in this sequence was filed on 28 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTOO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +22,727
- Change %
- +18%
- Price
-
- Shares after
- 150,936
- Date
- 06 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TTOO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -22,727
- Change %
- -50%
- Price
-
$0.000000
- Shares after
- 22,727
- Date
- 06 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,727
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes